Your Position:Home>Products>Monoclonals/Polyclonals>Anti-Human Endoglin/CD105 Reference Antibody

Anti-Human Endoglin/CD105 Reference Antibody

  • Cat. No.:RB9THB604016
  • Price:Negotiable
  • Clicks:235

Product Detail

Product Parameters

FormLiquid
Host SpeciesChimeric
ClonalityMonoclonal
IsotypeIgG1-kappa
Purity>95% purity as determined by SDS-PAGE.
PurificationProtein A/G purified from cell culture supernatant.
Concentration1mg/ml
Endotoxin LevelPlease contact the lab for this information.
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Species ReactivityHuman
TargetCD105, END, Endoglin, ENG
Storage Buffer0.01M PBS, pH 7.4.
Stability and StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Expression SystemMammalian Cells
Accession NumberP17813
BackgroundCarotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions.
• Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease., PMID:36614087
• Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessel coronary artery disease., PMID:22463585
• Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining., PMID:15272276
• Antibody phage display technologies with special reference to angiogenesis., PMID:15746176
• Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells., PMID:23917399
• Generation of a Soluble Form of Human Endoglin Fused to Green Fluorescent Protein., PMID:34681942
• Synovial biomarkers in psoriatic arthritis., PMID:22751595
• Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide., PMID:11691802
• A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma., PMID:27328856
• Elabela gene therapy promotes angiogenesis after myocardial infarction., PMID:34291565
Alternative NamesTRC-105, c-SN6j, 1268714-50-6
NoteFor research use only. Not suitable for clinical or therapeutic use.
For Research Use Only. Not for Diagnostic Procedures.

Related Products:
Total 33055 records,Divided into 1653 pages,The 1 pages | First Prev Next Last
Live Chat
  • Tel:
  • WeChat ID: 15898894496
  • Add Message
  • 9:00 AM – 6:00 PM